Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03586024
Brief Title: Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas

First Submitted : July 3, 2018
First Submitted that Met QC Criteria : July 3, 2018
First Posted : July 13, 2018

Last Update Submitted that Met QC Criteria : May 5, 2021
Last Update Posted : May 7, 2021